Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-08
1996-08-27
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514372, 548205, 548214, A61K 31425
Patent
active
055501427
ABSTRACT:
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
REFERENCES:
patent: 5145860 (1992-09-01), Takasugi et al.
patent: 5217971 (1993-06-01), Takasugi et al.
patent: 5229386 (1993-07-01), Takasugi et al.
patent: 5474995 (1995-12-01), Ducharme et al.
O'Banion, et al., Proc. Natl. Acad. Sci., USA, vol. 89, pp. 4888-4892 (1992).
Lombardino, et al., Arzneim-Forsch. (Drug Res.), vol. 25, NR. 10, pp. 1629-1635 (1975).
Lombardino, Nonsteroidal Antiinflammatory Drugs, pp. 114-130 (1985).
Ducharme Yves
Gauthier Jacques Y.
Leblanc Yves
Leger Serge
Prasit Petpiboon
Ivy C. Warren
Merck Frosst Canada Inc.
Owens Amelia
Panzer Curtis C.
Rose David L.
LandOfFree
Phenyl heterocycles as cox-2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenyl heterocycles as cox-2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenyl heterocycles as cox-2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1056401